Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Crossfiled / Zepbound
4 stories named Zepbound, covered by 4 outlets. Each one is shown beside every other newsroom's version of the same event, with a link to the outlet that filed it.
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
The risk appears small and data is mixed, but FDA wants patients to be aware.
Dr. Jon LaPook joins "CBS Mornings" to break down the facts on a new warning about GLP-1 medications causing possible vision loss. Each weekday morning, "CBS Mornings" co-hosts Gayle King, Norah O'Donnell and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature r
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.